Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
Clinical trial NCT05021536 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05021536
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2024-01-19
- Enrollment
- 664
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.